Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

Cytochalasin E, an indispensable reagent for disrupting actin polymerization and advancing cell biology studies, has emerged ...

FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...

The clinical trial supply & logistics market grew from USD 26.20 billion in 2024 to USD 28.21 billion in 2025. It is expected to continue growing at a CAGR of 7.96%, reaching USD ...

Investing.com -- The life sciences and diagnostic tools sector is poised for growth in 2026, with several companies well-positioned to capitalize on improving market conditions. According to Bank of ...

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

The softgel capsules market offers growth via rising demand for plant-based options, tech advancements, and regulatory ...

The race to develop effective Alzheimer's treatments represents a multi-billion dollar opportunity, and Thermo Fisher Scientific is cementing its position as a critical data provider within this space ...

Fidelity MSCI Health Care Index ETF offers long-term growth potential, leveraging demographic tailwinds and biotech ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Revvity (NYSE:RVTY) and the ...